References
- Schraff S, Derkay CS, Burke B, et al. American Society of Pediatric Otolaryngology member’s experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg. 2004;103:1039–1042.
- Shah RK, Derkay C, DeMarcantonio M. Otolaryngology for the pediatrician. Update on recurrent respiratory papilloma-current thoughts and management. Bentham Science Publishers, Chapter 11. 2013. p. 163–177. DOI: 10.2174/97816080545961130101
- Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001;111(1):57–69.
- Derkay CS, Bluher AE. Update on recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2019;52(4):669–679.
- Clamp PJ, Saunders MW. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2013;77(3):323–328.
- Jackowska J, Piersiala K, Klimza H, et al. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis-review of the literature. Otolaryngol Pol. 2018;72(4):1–8.
- Gerein V, Rastorguev E, Gerein J, et al. Use of interferon-alpha in recurrent respiratory papillomatosis: 20 year follow-up. Ann Otol Rhinol Laryngol. 2005;114(6):463–471.
- Shikowitz MJ, Abramson AL, Steinberg BM, et al. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2005;131(2):99–105.
- Carifi M, Napolitano D, Morandi M, et al. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. 2015;11:731–738.
- Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res. 2003;23:3591–3600.
- Theresia C, Zheng J, Chen XY. Topical ALA-PDT as alternative therapeutic option in treatment recalcitrant dermatosis: report of 4 cases. Photodiagnosis Photodyn Ther. 2017;20:189–192.
- Derkay C, Malis D, Zalzal G, et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;108:935–937.
- Zhou C, Sun B, Wang F, et al. Coblation plus photodynamic therapy (PDT) for the treatment of juvenile onset laryngeal papillomatosis: case reports. World J Surg Oncol. 2014;29:275.
- Dedo HH, Jackler RK. Laryngeal papilloma: results of treatment with the CO2 laser and podophyllum. Ann Otol Rhinol Laryngol. 1982;91(4 Pt 1):425–430.
- Buchinsky FJ, Donfack J, Derkay CS, et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One 2008;3(5):e2263.
- Venkatesan NN, Pine HS, Underbrink MP. Recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2012;45(3):671–694.
- Dedo HH, Yu KC. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001;111(9):1639–1644.
- Li K, Dong W, Qiu L, et al. A new GSH-responsive prodrug of 5-aminolevulinic acid for photodiagnosis and photodynamic therapy of tumors. Eur J Med Chem. 2019;181:111582.
- Lieder A, Khan MK, Lippert BM. Photodynamic therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev. 2014;6:CD009810.